Medarex, Inc.

Medarex, Inc.

Medarex, Inc.

Overview
Date Founded

1987

Headquarters

707 State Road,Princeton, NJ 08540

Type of Company

Private

Employees (Worldwide)

10K - 1M

Industries

Other Business & Consulting Services
Pharmaceuticals
Biotechnology

Company Description

Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey.

Contact Data
Trying to get in touch with decision makers at Medarex, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Secretary, Senior Vice President & General Counsel

Chief Information Officer & Senior Vice President

Head-Investor Relations

Senior Director

Administration Executive

Director Technology

Triage Coordinator

Director-Corporate Communications

Director & Vice President

Treasurer & Director

Board of Directors

Treasurer & Director at Medarex, Inc.

Director & Vice President at Medarex, Inc.

Former Senior Vice President, Human Resources & Corporate Staff at Bristol-Myers Squibb Company

Paths to Medarex, Inc.
Potential Connections via
Relationship Science
You
Medarex, Inc.
Recent Transactions
Details Hidden

Bristol-Myers Squibb Company purchases Medarex, Inc.

Details Hidden

AVANT Immunotherapeutics, Inc. purchases Celldex Therapeutics, Inc. (Old) from Medarex, Inc.

Details Hidden

Medarex, Inc. issued Common Stock

Transaction Advisors
Accountant

Advised onMedarex, Inc. purchases GenPharm International, Inc.

Investment Advisor

Advised onBristol-Myers Squibb Company purchases Medarex, Inc.

Selling Group Member

Advised onMedarex, Inc. issued Common Stock

Associate

Advised onBristol-Myers Squibb Company purchases Medarex, Inc.

Chief Financial Officer & Executive Vice President

Advised onBristol-Myers Squibb Company purchases Medarex, Inc.

Legal Advisor

Advised onBristol-Myers Squibb Company purchases Medarex, Inc.

Non-Profit Donations & Grants
$150 - $499
2006
$100K - $250K
2004
Investors
Details Hidden

Through the GHV Fund LP, GreenHills Ventures invests in early-stage broad-based technologies and medical device companies. The firm's Earned Value Milestone investment approach focuses on key business drivers, financial performance and overall fiscal discipline. They strive to prepare companies for growth and follow-on investments with appropriate valuations. Investments range from $1 million to $5 million in companies with enterprise valuations of $5 million to $10 million or more

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Medarex, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Medarex, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Medarex, Inc..